EFV600+FTC200+TDF300mg tab/PAC-180No CTN

General description:
Efavirenz 600mg + Emtricitabine 200mg + Tenofovir Disoproxil Fumarate 300mg, equivalent to 245mg Tenofovir Disoproxil, film coated tablet, pack of 180 without outer carton.

Technical Specifications
Each film coated tablet contains Efavirenz 600mg and Emtricitabine 200mg and Tenofovir Disoproxil Fumarate 300 mg, equivalent to 245 mg Tenofovir Disoproxil as fixed dose combination.

Therapeutic class
Efavirenz is a Non Nucleoside Reverse Transcriptase Inhibitor (NNRTI)
Emtricitabine is a Nucleoside Reverse Transcriptase Inhibitor (NRTI)
Tenofovir is a Nucleotide Reverse Transcriptase Inhibitor (NtRTI)

Dosage, Instructions for use:
For more details, please see WHO treatment guidelines www.who.int/hiv/pub/guidelines/en/index.html and WHO Essential Medicines Library www.who.int/emlib/ or your regional/national guidelines.

Details about paediatric dosage schemes can be found at http://www.who.int/hiv/topics/paediatric/en/index.html

WHO generic tool for assessing paediatric ARV dosing
http://www.who.int/hiv/paediatric/generictool/en/

Indications
Management of HIV-1 infection in children and adults in combination with at least two other antiretroviral drugs. By mouth (oral) PO.

Shelf life:
24 months

Storage conditions:
Do not store above 30°C.

Other available formulations
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.